Bomaz

Bomaz3 mg

Tablet

Bromazepam

Sharif Pharmaceuticals Ltd.

Product Code : 2380
MRP 4.01
10% Off
Best PriceTk
/
Out Of Stock
1
Section

Alternatives

See All
Product Image
8% Off

Lexotanil3 mg

Bromazepam

Radiant Pharmaceuticals Ltd.

8.28
9.00
Add to cart
Product Image
10% Off

Tenil3 mg

Bromazepam

ACME Laboratories Ltd.

6.30
7.00
Add to cart
Product Image
10% Off

Laxyl3 mg

Bromazepam

Square Pharmaceuticals Ltd.

4.52
5.02
Add to cart
Product Image
7% Off

Xionil3 mg

Bromazepam

SANDOZ (A Novartis Division)

4.74
5.10
Add to cart
Product Image
10% Off

Siesta3 mg

Bromazepam

Incepta Pharmaceuticals Ltd.

3.60
4.00
Add to cart
Product Image
10% Off

Bopam3 mg

Bromazepam

Opsonin Pharma Ltd.

4.72
5.25
Add to cart
Product Image
10% Off

Nightus3 mg

Bromazepam

Beximco Pharmaceuticals Ltd.

2.70
3.00
Add to cart
Product Image
10% Off

Lexopil3 mg

Bromazepam

Healthcare Pharmacuticals Ltd.

45.00
50.00
Add to cart
Product Image
10% Off

Norry3 mg

Bromazepam

Renata Limited

4.50
5.00
Add to cart
Product Image
10% Off

Restol3 mg

Bromazepam

Eskayef Bangladesh Ltd.

5.40
6.00
Add to cart
Product Image
10% Off

Freten3 mg

Bromazepam

Delta Pharma Ltd.

2.70
3.00
Add to cart
Product Image
10% Off

Broze3 mg

Bromazepam

Biopharma Laboratories Ltd.

4.52
5.02
Add to cart
Product Image
10% Off

Notens3 mg

Bromazepam

Aristopharma Ltd.

4.50
5.00
Add to cart
Product Image
10% Off

Anxio3 mg

Bromazepam

Unimed Unihealth MFG. Ltd.

4.05
4.50
Add to cart
Product Image
10% Off

Bromazep3 mg

Bromazepam

Orion Pharma Ltd.

3.61
4.01
Add to cart
Product Image
10% Off

Tenapam3 mg

Bromazepam

General Pharmaceuticals Ltd.

4.51
5.01
Add to cart
Product Image
10% Off

Zepam3 mg

Bromazepam

ACI Limited

4.52
5.02
Add to cart
Product Image
10% Off

Anxionil3 mg

Bromazepam

NIPRO JMI Pharma Ltd.

45.18
50.20
Add to cart
Product Image
10% Off

Relaxaid3 mg

Bromazepam

Labaid Pharma Ltd.

4.50
5.00
Add to cart
Product Image
10% Off

Tarbo3 mg

Bromazepam

Pharmasia Limited

4.50
5.00
Out Of Stock
Product Image
10% Off

Tensfree3 mg

Bromazepam

Globe Pharmaceuticals Ltd.

4.05
4.50
Add to cart
Product Image
10% Off

Tynaxie3 mg

Bromazepam

Navana Pharmaceuticals Ltd.

4.52
5.02
Add to cart
Product Image
10% Off

Zerotens3 mg

Bromazepam

Popular Pharmaceuticals Ltd.

3.60
4.00
Add to cart
Section

Medicine overview

Indications of Bomaz 3 mg

Bomaz 3 mg is indicated in- Emotional disturbances, i.e. acute tension and anxiety states. Difficulties in interpersonal contact. Agitation, insomnia, anxious and agitated depressive reactions. Functional disturbances in the cardiovascular and respiratory systems, i.e. pseudoangina pectoris, pericardial anxiety, tachycardia, emotiogenic hypertension, dyspnea and hyperventilation. ... Read moreBomaz 3 mg is indicated in- Emotional disturbances, i.e. acute tension and anxiety states. Difficulties in interpersonal contact. Agitation, insomnia, anxious and agitated depressive reactions. Functional disturbances in the cardiovascular and respiratory systems, i.e. pseudoangina pectoris, pericardial anxiety, tachycardia, emotiogenic hypertension, dyspnea and hyperventilation. Disturbances in the gastrointestinal tract, i.e. irritable bowel syndrome, epigastric pain, spasm, bloating diarrhea etc. Disturbances in the urinary tract, i.e. frequency, irritable bladder and dysmenorrhea. Psychosomatic disorder, i.e. psychogenic headache, asthma, gastric and duodenal ulcer. It is also indicated in emotional reactions to chronic organic disease.

Theropeutic Class

Benzodiazepine sedatives

Pharmacology

Bomaz 3 mg is a powerful psychotropic agent. In lower dosage, it selectively reduces tension and anxiety. In higher dosage, it shows sedative and muscle-relaxant properties.Bomaz 3 mg binds to the GABA-A receptor producing a conformational change and potentiating its inhibitory effects. Other neurotransmitters are not influenced.

Dosage of Bomaz 3 mg

Standard dosage: Average dosage for outpatient therapy is 1.5-3 mg up to three times daily. Treatment of outpatients should begin with low doses, gradually increasing to the optimum level. In severe cases, especially in hospital: 6-12 mg 2 or 3 times daily. The overall treatment generally should not be more than 8-12 weeks. In certain cases extension beyond the maximum treatment period may be necessary; if so, it should be taken with re-evaluation of the patient's status with special expertise.Elderly and debilitated patients: Elderly patients and those with impaired hepatic functions require lower doses.Children: Bomaz 3 mg is usually not indicated in children, but if the physician feels Bomaz 3 mg treatment is appropriate, then the dose should be adjusted to their low bodyweight (about 0.1-0.3 mg/kg bodyweight)

Administration of Bomaz 3 mg

Bomaz 3 mg tablets are for oral administration

Interaction of Bomaz 3 mg

If Bomaz 3 mg is combined with other centrally active drugs, its sedative effects may be enhanced. These drugs are antidepressants, hypnotics, narcotics, antipsychotics, sedatives, antiepileptic drugs, sedative antihistamines and anesthetics. Co-administration of cimetidine may prolong the eliminiation half-life of Bomaz 3 mg. Concomitant intake of Bomaz 3 mg with alcohol should be avoided, because the sedative effect of Bomaz 3 mg may be intensified by alcohol.

Contraindications

Bomaz 3 mg is contraindicated in patients with known hypersensitivity to Bomaz 3 mg, severe respiratory insufficiency, severe hepatic insufficiency or sleep apnea syndrome.

Side Effects of Bomaz 3 mg

Common side-effects include fatigue, drowsiness, muscle weakness, numbed muscle, reduced alertness, confusion, headache, ataxia etc. These phenomena occur predominantly at the start of therapy and usually disappear with prolonged administration. Anterograde amnesia may occur using therapeutic doses.

Pregnancy & Lactation

The safety of Bomaz 3 mg during pregnancy has not been established. As Bomaz 3 mg is excreted in breast milk, use should be avoided during lactation.

Precautions & Warnings

The use of benzodiazepines and benzodiazepine like agents may lead to the development of physical and psychological dependence upon these products. This dependence depends on the dose and duration of treatment; it is also greater in predisposed patients with a history of alcohol. Once physical dependence has developed, termination of the treatment will be accompanied by withdrawal symptoms. These may consist of headache, muscle pain, extreme anxiety, tension, confusion and irritability. Since the risk of withdrawal phenomena and rebound phenomena is greater after abrupt discontinuation of the treatment, it is recommended that the dosage be decreased gradually. Bomaz 3 mg is not recommended for the primary treatment of sleeplessness caused by psychotic illness. Caution should be exercised while driving cars or using machineries.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Drug Classes

Benzodiazepine sedatives

Mode Of Action

Bomaz 3 mg is a powerful psychotropic agent. In lower dosage, it selectively reduces tension and anxiety. In higher dosage, it shows sedative and muscle-relaxant properties. Bomaz 3 mg binds to the GABA-A receptor producing a conformational change and potentiating its inhibitory effects. Other neurotransmitters are not influenced.

Pregnancy

The safety of Bomaz 3 mg during pregnancy has not been established. As Bomaz 3 mg is excreted in breast milk, use should be avoided during lactation.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.